CENTURY THERAPEUTICS INC (IPSC)

US15673T1007 - Common Stock

1.07  +0.01 (+0.94%)

After market: 1.0719 +0 (+0.18%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
2.69M2.23M5.20M0.000.00
Operating Expenses
134.16M127.42M129.03M94.88M49.18M
Research and Development
100.17M92.71M97.17M75.65M39.68M
Selling, General, and Administrative Expenses
33.99M34.71M31.86M19.24M9.50M
Operating Income
-131.47M-125.18M-123.83M-94.88M-49.18M
Interest Income/Expense
13.63M12.14M-1.43M-1.28M-380.00K
Other Income/Expense
234.00K-383.00K4.42M380.00K700.00K
Non Recurring Items
N/A-21.36M-10.00M0.00-4.72M
Income Before Taxes
-130.75M-134.79M-130.84M-95.78M-53.58M
Income Tax
-854.00K1.88M90.00K40.00KN/A
Net Income
-129.89M-136.67M-130.93M-95.82M-53.58M
EBITDA
-117.93M-112.14M-115.39M-91.13M-47.78M
 
Per Share Data
EPS Diluted Total Ops
-1.86-2.30-2.27-2.96-7.16
Non GAAP EPS
-1.85-2.29-2.28N/AN/A
 
Statistics
Profit Margin
-4837.73%-6115.12%-2517.88%N/AN/A
Operating Profit Margin
-4896.46%-5600.94%-2381.35%N/AN/A

All data in USD

Charts